去卵巢大鼠肌肉衰减症模型构建及雌激素补充治疗的实验研究

黄昱彬; 凌丽; 熊正爱

doi:10.16016/j.2097-0927.202303072

您当前的位置：

首页 >

文章列表页 >

去卵巢大鼠肌肉衰减症模型构建及雌激素补充治疗的实验研究

基础医学 | 更新时间：2026-01-09

- 去卵巢大鼠肌肉衰减症模型构建及雌激素补充治疗的实验研究
- Establishment of rat model of sarcopenia by ovariectomy and estrogen replacement therapy
- 陆军军医大学学报 2023年45卷第18期页码：1937-1946
- 作者机构：
  
  400010 重庆，重庆医科大学附属第二医院妇产科
- 作者简介：
  
  [熊正爱, E-mail: docxza@163.com XIONG Zheng'ai, E-mail: docxza@163.com
- 基金信息：
- DOI：10.16016/j.2097-0927.202303072
  中图分类号： R589.305;R711.51;R977.12
- 收稿：2023-03-14，
  
  修回：2023-05-30，
  
  纸质出版：2023-09-30
- 稿件说明：
移动端阅览
黄昱彬, 凌丽, 熊正爱. 去卵巢大鼠肌肉衰减症模型构建及雌激素补充治疗的实验研究[J]. 陆军军医大学学报, 2023,45(18):1937-1946.

Yubin HUANG, Li LING, Zheng'ai XIONG. Establishment of rat model of sarcopenia by ovariectomy and estrogen replacement therapy[J]. Journal of Army Medical University, 2023, 45(18): 1937-1946.
黄昱彬, 凌丽, 熊正爱. 去卵巢大鼠肌肉衰减症模型构建及雌激素补充治疗的实验研究[J]. 陆军军医大学学报, 2023,45(18):1937-1946. DOI： 10.16016/j.2097-0927.202303072.

Yubin HUANG, Li LING, Zheng'ai XIONG. Establishment of rat model of sarcopenia by ovariectomy and estrogen replacement therapy[J]. Journal of Army Medical University, 2023, 45(18): 1937-1946. DOI： 10.16016/j.2097-0927.202303072.

摘要

目的

建立SD大鼠绝经后肌肉衰减症模型，观察雌激素补充对肌肉衰减症的治疗作用。

方法

① 44只12周龄雌性SD大鼠(体质量220±20 g)按体质量分层随机抽样分为假手术(SHAM)组、去卵巢(ovariectomized

X)组，每组22只。OVX组行双侧卵巢切除术，SHAM组行假手术，监测体质量，电子抓力仪测量大鼠前肢抓力，12周后通过双能X射线分析仪(DXA)分析身体成分，通过相对瘦质量判定建模是否成功，而后每组各处死10只取腓肠肌，用腓肠肌质量/体质量得出肌肉衰减症指数(sarcopenia index

SI)，HE染色观察腓肠肌肌纤维横截面积，电镜下观察肌原纤维超微结构。②余下大鼠进一步分为假手术(SHAM)组、假手术+油剂注射(SHAM+O)组、去卵巢(OVX)组、去卵巢+雌激素补充(OVX+E

)组，每组6只，OVX+E

组每日予以17β-雌激素腹部皮下注射，SHAM+O组每日予以10% DMSO+90%芝麻油皮下注射，监测体质量、前肢抓力，干预8周后DXA分析体成分，ELISA法测量血清E

、FSH，HE染色观察腓肠肌肌纤维横截面积，电镜下观察肌原纤维超微结构，免疫荧光染色分析Bax、Bcl-2的表达。

结果

① 建模12周后，OVX组相对瘦质量显著降低(

0.001)，提示建模成功，体质量(

0.001)、体脂率显著升高(

0.001)，相对抓力(

0.001)、SI值、肌纤维横截面积显著降低(

0.01)，电镜下线粒体密度降低(

=0.012)。②经雌激素补充治疗后，OVX+E

组抓力、相对瘦质量、体质量、体脂率、肌纤维横截面积、电镜下线粒体密度均恢复到SHAM组水平；免疫荧光显示OVX组较SHAM与OVX+E

组Bcl-2/Bax显著降低(

0.01)。

结论

成功建立了大鼠绝经后肌肉衰减症模型，雌激素补充治疗能显著改善去卵巢大鼠的肌肉衰减，可能与雌激素抑制肌细胞凋亡有关。

Abstract

Objective

To establish a rat model of postmenopausal sarcopenia and explore the therapeutic effect of estrogen supplementary therapy on the disease.

Methods

① Forty-four 12-week-old female SD rats (220±20 g) were randomly divided into sham group and ovariectomized (OVX) group by stratified random sampling based on body weight

with 22 rats in each group. The rats of the OVX group were given bilateral ovariectomy

while those of the SHAM group underwent sham surgery. The body weight was monitored

and the grip strength of the forelimb was measured using an electronic grip strength meter. In 12 weeks after surgery

the body composition was analyzed by X-ray absorptiometry (DXA) to identify the model establishment by relative lean mass. Ten rats in each group were sacrificed to harvest the gastrocnemius

and then sarcopenia index (SI) was calculated as the ratio of gastrocnemius mass to body weight. HE staining and transmission ele

ctron microscopy were applied respectively to observe the cross-sectional area of the muscle fibers and the structure of myofibrils were determined. ② The remaining rats were further divided into SHAM group

SHAM+O group

OVX group and OVX+E

group

with 6 rats in each group. 17β-estradiol was injected subcutaneously in OVX+E

group

while control solvent (10% DMSO+90%sesame oil) was injected subcutaneously in SHAM+O group. The grip strength and body composition were measured and body composition was analyzed. ELISA was used to measure the serum levels of E

and FSH

HE staining was employed to observe the cross-sectional area of gastrocnemius muscle fibers

electron microscopy was conducted to observe the ultrastructure of myofibrils

and immunofluorescence staining was applied to analyze the expression of Bax and Bcl-2.

Results

① After 12 weeks of modeling

the rats in the OVX group had significant lower relative lean mass (

0.001)

indicating the successful establishment of sarcopenia model

and had obviously increased body weight (

0.001) and body fat rate (

0.001)

but decreased relative grip (

0.001)

SI value

average cross sectional area of the muscle fibers (

0.01)

and mitochondrial density (

=0.012). ② Estrogen supplementary therapy resulted in similar body weight

body fat rate

grip strength

relative lean mass

SI value

average cross sectional area of the muscle fibers

and mitochondrial density in the rats in OVX+E

group when compared with those of SHAM group. Immunofluorescence assay re vealed that OVX group had a notably lower Bcl-2/Bax ratio than the SHAM and OVX+E

groups (

0.01).

Conclusion

A rat model of postmenopausal sarcopenia is successfully established. Estrogen supplementary therapy can significantly improve the muscle mass loss in ovariectomized rats

which may be associated with estrogen inhibiting myocyte apoptosis.

关键词

Keywords

references

姜珊, 康琳, 刘晓红. 2019亚洲肌少症诊断及治疗共识解读[J]. 中华老年医学杂志, 2020, 39(4): 373-376. DOI: 10.3760/cma.j.issn.0254-9026.2020.04.002.

JIANG S, KANG L, LIU X H. Interpretation of Asian Working Group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. Chin J Geriatr, 2020, 39(4): 373-376. DOI: 10.3760/cma.j.issn.0254-9026.2020.04.002.

CHEN L K, WOO J, ASSANTACHAI P, et al . Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J ] . J Am Med Dir Assoc, 2020, 21(3): 300-307. e2. DOI: 10.1016/j.jamda.2019.12.012.

李春微, 于康. 肌肉衰减症发病机制研究进展及其对临床诊断的指导意义[J]. 中国科学(生命科学), 2021, 51(8): 1170-1179. DOI: 10.1360/SSV-2021-0188.

LI C W, YU K. Research progress on pathogenesis of muscular dystrophy and its guiding significance for clinicaldiagnosis[J]. Sci Sin Vitae, 2021, 51(8): 1170-1179. DOI: 10.1360/SSV-2021-0188.

GAO J X, QIU Y D, HOU Y F, et al . Influencing factors for the decline of limb muscle strength and the association with all-cause mortality: evidence from a nationwide population-based cohort study[J ] . Aging Clin Exp Res, 2022, 34(2): 399-407. DOI: 10.1007/s40520-021-01940-w.

夏晓妹, 王红, 姬艳博, 等. 中国社区老年人肌肉衰减症影响因素的Meta分析[J]. 现代预防医学, 2022, 49(5): 946-950, 960. DOI: 10.16821/j.cnki.hsjx.2021.04.010.

XIA X M, WANG H, JI Y B, et al . A meta-analysis of the influencing factors of sarcopenia among the elderly in Chinese community[J ] . Mod Prev Med, 2022, 49(5): 946-950, 960. DOI: 10.16821/j.cnki.hsjx.2021.04.010.

常建英, 黄蓓, 蒋铁建. 绝经后女性肌少症[J]. 中国骨质疏松杂志, 2019, 25(9): 1345-1350. DOI: 10.3969/j.issn.1006-7108.2019.09.028.

CHANG J Y, HUANG B, JIANG T J. Sarcopenia in postmenopausal women[J]. Chin J Osteoporos, 2019, 25(9): 1345-1350. DOI: 10.3969/j.issn.1006-7108.2019.09.028.

HANSEN M. Female hormones: do they influence muscle and tendon protein metabolism?[J]. Proc Nutr Soc, 2018, 77(1): 32-41. DOI: 10.1017/S0029665117001951.

ENNS D L, TⅡDUS P M. The influence of estrogen on skeletal muscle[J]. Sports Med, 2010, 40(1): 41-58. DOI: 10.2165/11319760-000000000-00000.

GERACI A, CALVANI R, FERRI E, et al . Sarcopenia and menopause: the role of estradiol[J ] . Front Endocrinol (Lausanne), 2021, 12: 682012. DOI: 10.3389/fendo.2021.682012.

KENNY A M, DAWSON L, KLEPPINGER A, et al . Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estrogen-replacement therapy[J ] . J Gerontol A Biol Sci Med Sci, 2003, 58(5): M436-M440. DOI: 10.1093/gerona/58.5.m436.

PINGEL J, LANGBERG H, SKOVGÅRD D, et al . Effects of transdermal estrogen on collagen turnover at rest and in response to exercise in postmenopausal women[J ] . J Appl Physiol (1985), 2012, 113(7): 1040-1047. DOI: 10.1152/japplphysiol.01463.2011.

RONKAINEN P H, PÖLLÄNEN E, ALÉN M, et al . Global gene expression profiles in skeletal muscle of monozygotic female twins discordant for hormone replacement therapy[J ] . Aging Cell, 2010, 9(6): 1098-1110. DOI: 10.1111/j.1474-9726.2010.00636.x.

周晓宁, 袁帅, 赵启, 等. 肌少症造模方法的研究进展[J]. 中国骨质疏松杂志, 2022, 28(9): 1365-1368. DOI: 10.3969/j.issn.1006-7108.2022.09.022.

ZHOU X N, YUAN S, ZHAO Q, et al . Research progress in modeling methods of sarcopenia[J ] . Chin J Osteoporos, 2022, 28(9): 1365-1368. DOI: 10.3969/j.issn.1006-7108.2022.09.022.

杨璇, 王玉波, 于佳. 肌少症动物模型研究进展[J]. 脑与神经疾病杂志, 2022, 30(5): 328-330, F0003, 324. DOI: 10.1002/jcsm.12460.

YANG X, WANG Y B, YU J. Research progress of animal models ofsarcopenia[J]. J Brain Nerv Dis, 2022, 30(5): 328-330, F0003, 324. DOI: 10.1002/jcsm.12460.

EDSTRÖM E. Sarcopenia[M]. Stockholm: Karolinska Institutet, 2005: 12-24.

沈丽晓, 袁博云, 王丽, 等. 17β-雌二醇/微小核糖核酸-21信号通路抑制低氧性肺动脉高压肺血管重构的机制研究[J]. 中国循环杂志, 2018, 33(11): 1118-1123. DOI: 10.3969/j.issn.1000-3614.2018.11.017.

SHEN L X, YUAN B Y, WANG L, et al . 17β-estradiol attenuates hypoxia-induced pulmonary vascular remodeling via downregulating miRNA-21 signaling pathway[J ] . Chin Circ J, 2018, 33(11): 1118-1123. DOI: 10.3969/j.issn.1000-3614.2018.11.017.

辛薇, 祁珊珊, 曾海涛. 雌激素对去卵巢骨质疏松大鼠子宫组织形态的影响[J]. 黑龙江畜牧兽医, 2016(8): 220-222, 299.

XIN W, QI S S, ZENG H T. Effect of estrogen on uterine tissue morphology in ovariectomized osteoporosis rats[J]. Heilongjiang Animal Sci Vet Med, 2016(8): 220-222, 299.

SZEGEZDI E, MACDONALD D C, NÍ CHONGHAILE T, et al . Bcl-2 family on guard at the ER[J ] . Am J Physiol Cell Physiol, 2009, 296(5): C941-C953. DOI: 10.1152/ajpcell.00612.2008.

CAPLLONCH-AMER G, SBERT-ROIG M, GALMÉS-PASCUAL B M, et al . Estradiol stimulates mitochondrial biogenesis and adiponectin expression in skeletal muscle[J ] . J Endocrinol, 2014, 221(3): 391-403. DOI: 10.1530/JOE-14-0008.

黄驰欢, 刘静, 徐道明, 等. 肌肉质量测定方法的研究新进展[J]. 中国骨质疏松杂志, 2022, 28(9): 1385-1389. DOI: 10.3969/j.issn.1006-7108.2022.09.026.

HUANG C H, LIU J, XU D M, et al. New research advances in muscle mass determination methods[J]. Chin J Osteoporos, 2022, 28(9): 1385-1389. DOI: 10.3969/j.issn.1006-7108.2022.09.026.

CRUZ-JENTOFT A J, BAHAT G, BAUER J, et al . Sarcopenia: revised European consensus on definition and diagnosis[J ] . Age Ageing, 2019, 48(4): 601. DOI: 10.1093/ageing/afz046.

SAYED R K, DE LEONARDIS E C, GUERRERO-MARTÍNEZ J A, et al . Identification of morphological markers of sarcopenia at early stage of aging in skeletal muscle of mice[J ] . Exp Gerontol, 2016, 83: 22-30. DOI: 10.1016/j.exger.2016.07.007.

LEDUC-GAUDET J P, HUSSAIN S N A, BARREIRO E, et al . Mitochondrial dynamics and mitophagy in skeletal muscle health and aging[J ] . Int J Mol Sci, 2021, 22(15): 8179. DOI: 10.3390/ijms22158179.

RIBAS V, DREW B G, ZHOU Z Q, et al . Skeletal muscle action of estrogen receptor α is critical for the maintenance of mit ochondrial function and metabolic homeostasis in females[J ] . Sci Transl Med, 2016, 8(334): 334ra54. DOI: 10.1126/scitranslmed.aad3815..

VASCONSUELO A, PRONSATO L, RONDA A C, et al . Role of 17β-estradiol and testosterone in apoptosis[J ] . Steroids, 2011, 76(12): 1223-1231. DOI: 10.1016/j.steroids.2011.08.001.

COLLA A L, VASCONSUELO A, MILANESI L, et al . 17β-estradiol protects skeletal myoblasts from apoptosis through p53, bcl-2, and FoxO families[J ] . J Cell Biochem, 2017, 118(1): 104-115. DOI: 10.1002/jcb.25616.

程金娜, 张林, 耿雪, 等. Bcl-2家族对骨骼肌细胞运动适应性的调控机制研究进展[J]. 中国运动医学杂志, 2019, 38(1): 74-80. DOI: 10.3969/j.issn.1000-6710.2019.01.012.

CHENG J N, ZHANG L, GENG X, et al . Research progress on the regulatory mechanism of Bcl-2 family on the exercise adaptability of skeletal muscle cells[J ] . Chin J Sports Med, 2019, 38(1): 74-80. DOI: 10.3969/j.issn.1000-6710.2019.01.012.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

MiR-616在骨肉瘤中的表达及对其细胞增殖、凋亡、迁移侵袭的作用

Gm49394对胰岛β细胞凋亡的调控及机制研究

Kallistatin诱导SIRT1表达抑制人髓核细胞凋亡及细胞外基质降解

小鼠急性肾损伤致远端肺凋亡和程序性坏死的时程变化

锌指蛋白A20对LPS刺激时人退变髓核细胞衰老与凋亡的影响